Platelet-rich plasma in the management of osteochondral lesions of the talus of 1–2 stage

Kalinskiy Boris Markovich, Kashcheev Anton Andreevich, Kashcheev Grigory Andreevich

The treatment of most orthopedic diseases and the consequences of traumatic injury is a serious problem for modern traumatology. The use of treatment methods using cellular technologies can improve the results of therapy. However, the problem osteochondral lesions block talus is very important in modern traumatology and orthopedics. The article presents the results of treatment of 8 patients with osteochondral lesions of the talus 1-2 art. of different Genesis, which for the period from 2016 to 2019 was performed an arthroscopic debridement of the ankle joint with subchondral introduction of PRP. 7 patients underwent similar surgery without the introduction of PRP. The average age of patients was 26 years, the average duration of the disease — 4 years. As a result of the performed surgeries, the average score on the ACFAS scale in the main group increased from 62 to 92 after surgery, in the control group from 62 to 85 after surgery (the follow-up period was 2 years on average).

Keywords:platelet-rich plasma, PRP, osteochondral lesion, talus, arthroscopy.